| Avanafil |
Tablet |
II (Paddle) |
50 |
Simulated gastric fluid without pepsin. |
900 |
5, 10, 15, 20 and 30 |
2015/04/02 |
| Avapritinib |
Tablet |
II (Paddle) |
75 |
0.05 M Sodium Acetate Buffer, pH 5.0 containing 0.5% w/v cetyl trimethylammonium bromide (CTAB) |
900 |
5, 10, 15, 20, 30, 45, 60, 90 and 120 |
2022/05/12 |
| Axitinib |
Tablet |
II (Paddle) |
75 |
0.01 N HCl |
900 |
5, 15, 30, 45 and 60 |
2014/08/14 |
| Azacitidine |
Tablet |
II (Paddle) |
75 |
50 mM phosphate buffer, pH 6.8 |
500 |
5, 10, 15, 20, 30 and 45 |
2023/11/30 |
| Azacitidine |
Injectable Suspension |
|
|
Develop a dissolution method |
|
|
2008/09/03 |
| Azathioprine |
Tablet |
|
|
Develop a dissolution method |
|
|
2024/01/03 |
| Azilsartan Kamedoxomil |
Tablet |
II (Paddle) |
50 |
Phosphate Buffer, pH 7.8 (deaerated) |
900 |
5, 10, 15, 20, 30 and 45 |
2013/05/09 |
| Azilsartan Kamedoxomil/Chlorthalidone |
Tablet |
II (Paddle) |
50 |
Phosphate Buffer, pH 6.8 containing 1.0% Tween 80, |
900 |
5, 10, 15, 20, 30 and 45 |
2013/05/09 |
| Azithromycin |
Suspension (Extended Release) |
II (Paddle) |
50 |
Phosphate Buffer, pH 6.0 |
900 |
15, 30, 45, 60, 120 and 180 |
2008/04/15 |
| Azithromycin |
Oral Suspension |
II (Paddle) |
50 |
Phosphate buffer, pH 6.0 |
900 |
10, 20, 30, and 45 |
2006/08/17 |
| Azithromycin |
Tablet |
|
|
Refer to USP |
|
|
2016/12/22 |
| Azithromycin |
Capsule |
|
|
Refer to USP |
|
|
2016/12/22 |
| Baclofen |
Suspension |
II (Paddle) |
25 |
0.01 N HCl |
500 |
5, 10, 15, 30, 45 and 60 |
2024/05/31 |
| Baclofen |
Granules |
II (Paddle) |
50 |
0.01 N HCl |
500 |
5, 10, 15 and 30 |
2024/02/05 |
| Baclofen |
Tablet |
|
|
Refer to USP |
|
|
2009/12/15 |
| Baclofen |
Tablet (Orally Disintegrating) |
II (Paddle) |
25 |
50 mM Acetate Buffer, pH 4.5 |
500 mL (10 mg) or 1000 mL (20mg) |
5, 10, 15 and 30 |
2008/07/14 |
| Baloxavir Marboxil |
Tablet |
II (paddle) |
50 |
20 mg: Phosphate Buffer, pH 6.8 with 0.07% w/v (CTAB); 40 mg: Phosphate Buffer, pH 6.8 with 0.16% w/v CTAB; 80 mg: Phosphate Buffer, pH 6.8 with 0.40 w/v cetyltrimethylammonium bromide (CTAB) |
900 |
5, 10, 15, 20, 30 and 45 |
2023/07/07 |
| Baloxavir Marboxil |
For Suspension |
II (Paddle) |
25 |
Phosphate Buffer, pH 6.8 containing 0.16% w/v cetyl trimethylammonium bromide (CTAB) |
900 |
5, 10, 15, 20 and 30 |
2023/02/09 |
| Balsalazide Disodium |
Capsule |
II (Paddle) with sinker |
50 |
pH 6.8 buffer |
900 |
10, 20, 30, and 45 |
2006/01/26 |
| Balsalazide Disodium |
Tablet |
|
|
Develop a dissolution method |
|
|
2023/09/15 |